Baird raised the firm’s price target on Alignment Healthcare (ALHC) to $28 from $22 and keeps an Outperform rating on the shares. The firm updated its model and sees a path to $59 per share representig a 163% upside.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare jumps after Baird analyst highlights on CNBC
- Alignment Healthcare price target raised to $28 from $21 at KeyBanc
- Alignment Healthcare appoints Mansour as Chief Digital Officer
- Alignment Healthcare price target raised to $25 from $18.50 at TD Cowen
- Alignment Healthcare price target raised to $21 from $18 at UBS